Paul Willis, MD
General Surgery · Mc Kees Rocks, PANPI 1104835180
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 89 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Davol Inc. at 29.9% of the total. Reporting peaked in 2022 at $638 and has fallen 50.5% since, to $316 in 2025. Among general surgery clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 89 payments — averaging $32.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Davol Inc.$856
- Medtronic$814
- Philips North America LLC$255
- TELA Bio, Inc.$205
- Johnson & Johnson$117
- Conmed Corporation$113
- plus $498 from 13 others
What the payments were for
- Food & beverage$2,80398%
- Gifts$562%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Davol Inc. | 43 | $856 |
| Medtronic(2 entities) | 13 | $814 |
| Philips North America LLC | 6 | $255 |
| TELA Bio, Inc. | 2 | $205 |
| Johnson & Johnson | 5 | $117 |
| Conmed Corporation | 1 | $113 |
| Intuitive Surgical | 3 | $91 |
| W. L. Gore & Associates, Inc. | 1 | $76 |
| Misonix Inc | 1 | $48 |
| Organogenesis Inc. | 3 | $47 |
| Pacira Pharmaceuticals Incorporated | 2 | $46 |
| Atricure, Inc. | 1 | $37 |
| Vertex | 1 | $31 |
| Innocoll Pharmaceuticals Limited | 2 | $29 |
| Bioventus LLC | 1 | $26 |
| Teleflex LLC | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Smith+Nephew | 1 | $16 |
| Cumberland Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,859 in reported general payments places this provider in the 90th percentile of 57 general surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 17 | $15,444 |
| ClopidogrelClopidogrel Bisulfate | 53 | $603 |
| Oxycodone Hcl | 51 | $152 |
Paid to pharmacies, not to this prescriber.
Other general surgery in Mc Kees Rocks
- Gary NealePlains$10K
- Sheri MorrisBeaver$10K
- Sarun SuwanNatrona Heights$7K
- Ramesh RamanathanPittsburgh$2K
- David GellerPittsburgh$2K
- David RossLancaster$2K
- Jason LucianoPittsburgh$2K
- Judy RossPittsburgh$975
- Sergio PerezPhiladelphia$521
- Amit BasuPittsburgh$311
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.